Mirae Asset Global Investments’s Dynavax Technologies DVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-5,706
| Closed | -$87.8K | – | 1611 |
|
|
2025
Q4 | $87.8K | Buy |
5,706
+1,172
| +26% | +$12.9K | ﹤0.01% | 1286 |
|
|
2025
Q3 | $45K | Sell |
4,534
-105
| -2% | -$1.09K | ﹤0.01% | 1364 |
|
|
2025
Q2 | $46K | Buy |
4,639
+487
| +12% | +$5.13K | ﹤0.01% | 1275 |
|
|
2025
Q1 | $56.8K | Sell |
4,152
-229
| -5% | -$3.03K | ﹤0.01% | 1218 |
|
|
2024
Q4 | $57K | Sell |
4,381
-359
| -8% | -$4.34K | ﹤0.01% | 1250 |
|
|
2024
Q3 | $52.1K | Buy |
4,740
+832
| +21% | +$9.17K | ﹤0.01% | 1296 |
|
|
2024
Q2 | $44.4K | Sell |
3,908
-75,742
| -95% | -$882K | ﹤0.01% | 1272 |
|
|
2024
Q1 | $844K | Sell |
79,650
-7,466
| -9% | -$97.4K | ﹤0.01% | 1629 |
|
|
2023
Q4 | $1.22M | Buy |
87,116
+6,296
| +8% | +$87.5K | ﹤0.01% | 1519 |
|
|
2023
Q3 | $1.19M | Buy |
80,820
+6,339
| +9% | +$89.2K | ﹤0.01% | 1433 |
|
|
2023
Q2 | $965K | Sell |
74,481
-5,179
| -7% | -$59K | ﹤0.01% | 1591 |
|
|
2023
Q1 | $781K | Buy |
79,660
+20,348
| +34% | +$217K | ﹤0.01% | 1674 |
|
|
2022
Q4 | $631K | Buy |
59,312
+1,077
| +2% | +$12.5K | ﹤0.01% | 1759 |
|
|
2022
Q3 | $608K | Buy |
58,235
+21,593
| +59% | +$281K | ﹤0.01% | 1757 |
|
|
2022
Q2 | $461K | Buy |
+36,642
| New | +$389K | ﹤0.01% | 1790 |
|
Other funds holding DVAX
Mirae Asset Global Investments's DVAX Position: Q1 2026 in Review
Mirae Asset Global Investments sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 5,706 shares — an estimated $87.8K sold.
Mirae Asset Global Investments first reported a position in DVAX in Q2 2022 and held it in 15 quarters. The position peaked at $1.22M in Q4 2023. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.
- Mirae Asset Global Investments reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
- Mirae Asset Global Investments sold 5,706 Dynavax Technologies shares in Q1 2026, an estimated $87.8K.
- Mirae Asset Global Investments first reported a position in Dynavax Technologies in Q2 2022 and held it in 15 quarters.
- Mirae Asset Global Investments's Dynavax Technologies position peaked at $1.22M in Q4 2023.
- 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.
Based on Mirae Asset Global Investments's 13F filing for Q1 2026, filed 4 May 2026.